{"id":"W2949917654","doi":"10.21037/atm.2019.05.86","title":"The PD-1/PD-L1 pathway in advanced prostate cancer—have we milked this cow?","year":2019,"lang":"en","type":"letter","venue":"Annals of Translational Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Prostate cancer; Medicine; Immunotherapy; Cancer; Oncology; PD-L1; Lung cancer; Internal medicine; Melanoma; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003358875,0.0007027428,0.001352719,0.0006614969,0.002673805,0.002357595,0.001478179,0.0259128,0.004863257],"category_scores_gemma":[0.01730193,0.0004799396,0.001023305,0.0006573021,0.002464021,0.004863149,0.0009151179,0.02808063,0.004667503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004266927,"about_ca_system_score_gemma":0.002538658,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003519864,"about_ca_topic_score_gemma":0.005917539,"domain_scores_codex":[0.9979381,0.0008237637,0.0002250111,0.0002566097,0.0005363849,0.000220157],"domain_scores_gemma":[0.9929301,0.004067021,0.0003868111,0.0001950153,0.001436864,0.0009842478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008576504,0.00004276179,0.0004280206,0.00008948467,0.00001461759,0.001982785,0.00007134203,0.00006832201,0.0001667509,0.001795134,0.978328,0.01692691],"study_design_scores_gemma":[0.0002676595,0.0002519884,0.00152571,0.0008819064,0.00006802679,0.008339978,0.000457823,0.001007555,0.0003715903,0.01678552,0.9699146,0.0001275702],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.0002237998,0.003757823,0.00007007676,0.9719989,0.02301154,0.000006579089,0.00001807862,0.00001553829,0.000897672],"genre_scores_gemma":[0.004609332,0.005533641,0.0002412249,0.8372988,0.1486554,0.00002134974,0.00002231731,0.00001790495,0.003599941],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.0259128,"threshold_uncertainty_score":0.03095889,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05676537123009357,"score_gpt":0.3445108657724363,"score_spread":0.2877454945423427,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}